Key Highlights of the Report: Several pharmaceutical companies is rapidly investing in research and development, thus driving the market growth during the forthcoming years. The high cost associated with the AAV gene therapy is one of the major challenge in its adoption among the patients. Increasing number of FDA approvals for AAV-based gene therapies, reflecting regulatory support and...